Riluzole serum concentrations in patients with ALS - Associations with side effects and symptoms

被引:39
作者
Groeneveld, GJ
Van Kan, HJM
Kalmijn, S
Veldink, JH
Guchelaar, HJ
Wokke, JHJ
Van den Berg, LH
机构
[1] Univ Utrecht, Med Ctr, Dept Neurol, NL-3584 CX Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Clin Pharm, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1212/01.WNL.0000090459.76784.49
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Riluzole exerts a dose-dependent effect on survival of patients with ALS and, although serum levels show a high interindividual variability, is usually prescribed in a fixed dose. In this study, riluzole serum levels and area under the curve per kilogram of body weight (AUC/kg) of 169 patients with ALS showed a high interindividual variability. Patients with high serum levels and AUC/kg more often had diarrhea but less often had fasciculations and muscle stiffness. It may therefore be advantageous to raise the riluzole dose in patients with low riluzole serum concentrations without the risk of serious side effects.
引用
收藏
页码:1141 / 1143
页数:3
相关论文
共 9 条
[1]   A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].
BENSIMON, G ;
LACOMBLEZ, L ;
MEININGER, V ;
BOUCHE, P ;
DELWAIDE, C ;
COURATIER, P ;
BLIN, O ;
VIADER, F ;
PEYROSTPAUL, H ;
DAVID, J ;
MALOTEAUX, JM ;
HUGON, J ;
LATERRE, EC ;
RASCOL, A ;
CLANET, M ;
VALLAT, JM ;
DUMAS, A ;
SERRATRICE, G ;
LECHEVALLIER, B ;
PEUCH, AJ ;
NGUYEN, T ;
SHU, C ;
BASTIEN, P ;
PAPILLON, C ;
DURRLEMAN, S ;
LOUVEL, E ;
GUILLET, P ;
LEDOUX, L ;
ORVOENFRIJA, E ;
DIB, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :585-591
[2]   El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis [J].
Brooks, BR ;
Miller, RG ;
Swash, M ;
Munsat, TL .
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (05) :293-299
[3]   Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis [J].
Bruno, R ;
Vivier, N ;
Montay, G ;
LeLiboux, A ;
Powe, LK ;
Delumeau, JC ;
Rhodes, GR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (05) :518-526
[4]   Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS [J].
Groeneveld, GJ ;
van Kan, HJM ;
Toraño, JS ;
Veldink, JH ;
Guchelaar, HJ ;
Wokke, JHJ ;
van den Berg, LH .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 191 (1-2) :121-125
[5]   A confirmatory dose-ranging study of riluzole in ALS [J].
Lacomblez, L ;
Bensimon, G ;
Leigh, PN ;
Guillet, P ;
Powe, L ;
Durrleman, S ;
Delumeau, JC ;
Meininger, V ;
Puech, AJ ;
Whitehead, J ;
Asselain, B ;
Cesaro, P ;
Larrey, D ;
Rossor, M ;
Zimmerman, HJ ;
Salzman, P ;
Doppler, V ;
Lloyd, CM ;
Maloteaux, JM ;
Delwaide, C ;
Laterre, EC ;
Bouchard, JP ;
Duquette, P ;
Girard, M ;
Masse, C ;
Eisen, A ;
Blin, O ;
Azulay, JP ;
BilleTurc, F ;
Pouget, J ;
Bouche, P ;
Camu, M ;
Carlander, B ;
Billiard, M ;
Clanet, M ;
Angibaud, G ;
ArneBes, MC ;
Benazet, M ;
Couratier, P ;
Vallat, JM ;
Desnuelle, C ;
Lagueny, A ;
Ellie, E ;
Dib, M ;
Rozier, A ;
Salachas, F ;
Viader, F ;
Delaunay, D ;
Dengler, R ;
Kuther, G .
NEUROLOGY, 1996, 47 (06) :S242-S250
[6]   Dose-ranging study of riluzole in amyotrophic lateral sclerosis [J].
Lacomblez, L ;
Bensimon, G ;
Leigh, PN ;
Guillet, P ;
Meininger, V .
LANCET, 1996, 347 (9013) :1425-1431
[7]  
LeLiboux A, 1997, J CLIN PHARMACOL, V37, P820
[8]   MW PHARM, AN INTEGRATED SOFTWARE PACKAGE FOR DRUG-DOSAGE REGIMEN CALCULATION AND THERAPEUTIC DRUG-MONITORING [J].
PROOST, JH ;
MEIJER, DKF .
COMPUTERS IN BIOLOGY AND MEDICINE, 1992, 22 (03) :155-163
[9]  
Sanderink GJ, 1997, J PHARMACOL EXP THER, V282, P1465